Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Surprise US FDA Facility Inspections Resume In India
May 24 2022
•
By
Derrick Gingery
The COVID-19 outbreak in China delayed the start of surprise inspections by the FDA. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance